Research graph
References from 5-Aminolevulinic Acid–mediated Photodynamic Therapy for Glioblastoma. Local targets link to admitted publications; unresolved targets remain external evidence.
The somatic genomic landscape of glioblastoma
10.1016/j.cell.2013.09.034 · 2013 · External reference
Barriers to T cell functionality in the glioblastoma microenvironment
10.3390/cancers16193273 · 2024 · External reference
Novel approaches to targeting gliomas at the leading/cutting edge
10.3171/2023.1.jns221798 · 2023 · External reference
Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: exploring a new frontier
10.3389/fimmu.2023.1057567 · 2023 · External reference
Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
10.18632/oncotarget.3554 · 2015 · External reference
Postoperative outcomes following glioblastoma resection using a robot-assisted digital surgical exoscope: a case series
10.1007/s11060-020-03543-3 · 2020 · External reference
Trends in immunotherapy clinical trials to treat glioblastoma: a look at progress and challenges
10.1016/j.wneu.2023.08.020 · 2023 · External reference
Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients
10.1093/neuonc/now036 · 2016 · External reference
Fluorescence-guided surgery for gliomas: past, present, and future
10.3390/cancers17111837 · 2025 · External reference
Use of intraoperative fluorophores
10.1016/j.nec.2020.08.001 · 2021 · External reference
5-ALA and FDA approval for glioma surgery
10.1007/s11060-019-03098-y · 2019 · External reference
Established and emerging uses of 5-ALA in the brain: an overview
10.1007/s11060-018-03087-7 · 2019 · External reference
5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas
10.1007/s11060-019-03103-4 · 2019 · External reference
Turning on the light for brain tumor surgery: a 5-aminolevulinic acid story
10.1093/neuonc/noac191 · 2022 · External reference
5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study
10.3171/2021.5.jns21310 · 2022 · External reference
Fluorescence-guided high-grade glioma surgery more than four hours after 5-aminolevulinic acid administration
10.3389/fneur.2021.644804 · 2021 · External reference
Fluorescence-guided surgery for high-grade gliomas: LAKOMKIN and HADJIPANAYIS
10.1002/jso.25154 · 2018 · External reference
Fluorescence-guided surgery and intraoperative photodynamic therapy for the treatment of glioblastoma: a technical case report
10.1007/s44499-025-00001-4 · 2026 · External reference
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
10.1371/journal.pmed.1000097 · 2009 · External reference
Interstitial photodynamic therapy for newly diagnosed glioblastoma
10.1007/s11060-023-04284-9 · 2023 · External reference
Interstitial photodynamic therapy using 5-ALA for malignant glioma recurrences
10.3390/cancers13081767 · 2021 · External reference
Interstitial photodynamic therapy of glioblastomas: a long-term follow-up analysis of survival and volumetric MRI data
10.3390/cancers15092603 · 2023 · External reference
Stereotactic photodynamic therapy of recurrent malignant gliomas
10.17691/stm2024.16.2.06 · 2024 · External reference
Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study
10.1007/s00701-024-06108-9 · 2024 · External reference
ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment
10.1615/jenvironpatholtoxicoloncol.v26.i2.110 · 2007 · External reference
Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial
10.1007/s11060-021-03718-6 · 2021 · External reference
ALA and photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre phase III randomised controlled trial
10.1007/s10103-007-0494-2 · 2008 · External reference
Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)
10.1007/s11060-024-04693-4 · 2024 · External reference
Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control
10.3171/2019.11.jns192443 · 2021 · External reference
Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX
10.1002/lsm.20507 · 2007 · External reference
Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report
10.1007/s11060-007-9497-x · 2008 · External reference
